Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an ...

CAMBRIDGE, England--(BUSINESS WIRE)--Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a ...

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing an ...

AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate ...

Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for ...

Shift Bioscience is building a cell simulation platform that combines generative AI with its highly accurate, high-throughput biological aging clock, to predict which sets of genes are most likely to ...